Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
Jean Albrengues, Thomas Bertero, Eloise Grasset, Stephanie Bonan, Majdi Maiel, Isabelle Bourget, Claude Philippe, Cecilia Herraiz Serrano, Samia Benamar, Olivier Croce, Victoria Sanz-Moreno, Guerrino Meneguzzi
Read Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts by Jean Albrengues, Thomas Bertero, Eloise Grasset, Stephanie Bonan, Majdi Maiel, Isabelle Bourget, Claude Philippe, Cecilia Herraiz Serrano, Samia Benamar, Olivier Croce, Victoria Sanz-Moreno, Guerrino Meneguzzi in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4682161.txt.
Introduction
Jean Albrengues, Thomas Bertero, Eloise Grasset, and nine colleagues studied how fibroblasts near tumors turn into helpers of cancer spread, publishing in Nature Communications. Fibroblasts are support cells that build the tissue around tumors. A signal called LIF can reprogram them into a state that remodels nearby tissue and helps cancer cells invade. The puzzle was how this harmful state stays switched on.
The team traced a chain of chemical marks on DNA and proteins that locks the state in place. One enzyme adds a mark to the STAT3 protein, which then raises a second enzyme that silences a brake gene called SHP-1. With the brake gone, a growth signal stays active on its own. Blocking both the marking enzymes and the signal, in lab tests and in animals, restored the normal fibroblast state. The findings name targets that might slow tumor invasion.
Catalog record
| CREATOR | Jean Albrengues, Thomas Bertero, Eloise Grasset, Stephanie Bonan, Majdi Maiel, Isabelle Bourget, Claude Philippe, Cecilia Herraiz Serrano, Samia Benamar, Olivier Croce, Victoria Sanz-Moreno, Guerrino Meneguzzi |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts By Jean Albrengues, Thomas Bertero, Eloise Grasset, Stephanie Bonan, Majdi Maiel, Isabelle Bourget, Claude Philippe, Cecilia Herraiz Serrano, Samia Benamar, Olivier Croce, Victoria Sanz-Moreno, Guerrino Meneguzzi Published in: Nature Communications DOI: 10.1038/ncomms10204 ABSTRACT Abstract Carcinoma-associated fibroblasts (CAF) mediate the onset of a proinvasive tumour microenvironment. The proinflammatory cytokine LIF reprograms fibroblasts into a proinvasive phenotype, which promotes extracellular matrix remodelling and collective invasion of cancer cells. Here we unveil that exposure to LIF initiates an epigenetic switch leading to the constitutive activation of JAK1/STAT3 signalling, which results in sustained proinvasive activity of CAF. Mechanistically, p300-histone acetyltransferase acetylates STAT3, which, in turn, upregulates and activates the DNMT3b DNA methyltransferase. DNMT3b methylates CpG sites of the SHP-1 phosphatase promoter, which abrogates SHP-1 expression, and results in constitutive phosphorylation of JAK1. Sustained JAK1/STAT3 signalling is maintained by DNA methyltransferase DNMT1. Consistently, in human lung and head and neck carcinomas, STAT3 acetylation and phosphorylation are inversely correlated with SHP-1 expression. Combined inhibition of DNMT activities and JAK signalling, in vitro and in vivo, results in long-term reversion of CAF-associated proinvasive activity and restoration of the wild-type fibroblast phenotype. Carcinoma-associated fibroblasts (CAF) are key components of solid tumour ecosystems, including breast, skin, head and neck, prostate and lung cancers1,2,3. CAF play an active role in tumour development and their presence within the tumour stroma is associated with poor clinical outcome4,5,6,7,8. Besides promoting primary tumours, CAF remodel the tumour microenvironment by generation of tensile forces within the extracellular matrix (ECM) that support favourable cues for tumour invasion9,10,11,12. CAF-dependent excessive ECM remodelling leads to tumour fibrosis, which is associated with tumour cell dissemination and metastasis13,14. CAF-dependent profibrotic activity is governed by constitutive activation of the Janus kinase 1 (JAK1), which leads to constitutive phosphorylation of its downstream target, the STAT3 (signal transducer and activator of transcription 3) transcription factor15. We have demonstrated that the proinflammatory LIF (leukaemia inhibitory factor) cytokine initiates the sustained proinvasive stromal fibroblast phenotype observed in cancers16. However, how the activated status of stromal fibroblast is sustained remains to be elucidated. STAT3 belongs to a large family of transcription factors, and its constitutive activation has been observed in 70% of solid and haematological tumours17. STAT3-dependent transcriptional activity is mediated by phosphorylation on tyrosines 705 and 727 by the JAK family kinases in response to cytokine-mediated signalling18. Activated STAT3 translocates to the nucleus and binds promoter DNA sequences to regulate targeted gene transcription. STAT3 activity is enhanced by acetylation on lysine 685 by the histone acetyltransferases (HAT) p300/CREB-binding protein (CBP), a post-transcriptional modification that is reversed by histone deacetylases (HDACs)19,20,21. Acetylated STAT3 binds to the DNA methyltransferase DNMT1, which mediates targeted gene silencing by methylation of promoter DNA sequences22. DNA methylation plays critical roles in control of sustained and constitutive activation of signalling pathways23. Overall, both tumour and stromal cell DNA are hypomethylated; however, hypermetylation of CpG dinucleotides in gene promoters is known to silence tumour-suppressor gene expression24,25,26,27,28. Among the major DNA methyltransferases (DNMTs), DNMT1 maintains pre-existing DNA methylation patterns along with DNA replication and cell division; DNMT3a and DNMT3b target unmethylated CpGs and introduce de novo methylations29. Here using combination of three-dimensional model of organotypic invasion assays of head and neck and breast tumours, and using in vitro and in vivo models of breast carcinomas, we demonstrate that an epigenetic switch initiates and maintains the proinvasive phenotype of CAF. We show that LIF induces constitutive activation of the JAK1/STAT3 signalling pathway by post-translational regulation of STAT3 acetylation by p300, in fibroblasts. Acetylated STAT3 leads to an epigenetic-dependent loss of expression of the SHP-1 tyrosine phosphatase, which is a negative regulator of the JAK/STAT pathway. Silencing of SHP-1 by promoter methylation leads to sustained constitutive phosphorylation of the JAK1 kinase and the STAT3 transcription factor that maintain the contractile and proinvasive fibroblasts abilities. Blockage of both JAK signalling and DNA methyltransferase activities both in vitro and in vivo results in long-term proinvasive phenotypic reversion of CAF. Finally, we corroborate our in vitro and in vivo findings through immunhistological analysis of STAT3 activity and SHP-1 expression in both head and neck and lung human carcinoma biopsies. Therefore, we conclude that in human carcinomas from different origins, LIF induces a sustained proinvasive activation of CAF through an epigenetic-dependent loss of SHP-1 phosphatase. RESULTS Epigenetic mechanisms sustain the proinvasive CAF phenotype We first assessed whether, similar to CAF isolated from head and neck, lung and breast human carcinomas (HN-CAF, Lu-CAF and Br-CAF, respectively), the long-term LIF or TGFβ-activated human dermal fibroblasts (hDF_LIF or hDF_TGFβ) constitutively retain their proinvasive properties. hDF were stimulated for 7 days in culture using LIF or TGFβ in the presence or absence of a LIF blocking antibody. After 15- 30- and 60-day culture in low serum concentration (Fig. 1a), the hDF proinvasive ability was assessed using a three-dimensional SCC12 cell organotypic invasion assay30. In these conditions LIF induced the sustained fibroblast proinvasive phenotype (Fig. 1b) and, constitutively, the JAK1/STAT3 signalling pathway (Supplementary Fig. 1a) as observed with CAF compared with primary hDF (Supplementary Fig. 1b). Interestingly, TGFβ, the major in vitro and in vivo CAF activator, relied on LIF to constitutively activate the proinvasive ability of hDF (Fig. 1b) and the JAK1/STAT3 signalling pathway (Supplementary Fig. 1a). These results indicate that a 7-day LIF stimulation is sufficient to confer a long-term proinvasive CAF-like phenotype to hDF. CAF secrete procarcinogenic factors, including interleukin-6 (IL6)-family cytokines2 that may sustain constitutive activation of JAK1 kinase via an autocrine regulatory loop. Therefore, we investigated whether media conditioned (CM) by CAF, hDF_LIF and hDF_TGFβ can activate JAK1/STAT3 signalling in hDF. Stimulation of hDF by long-term CAF, LIF- and TGFβ-activated hDF CM failed to promote JAK1/STAT3 phosphorylation (Fig. 1c) and collagen gel contraction (Fig. 1d), while short-term TGFβ-activated CM (hDF-TGFβ-6 h), in which LIF is detectable16, promoted both STAT3 phosphorylation and gel contraction (Fig. 1c,d). Accordingly, in hDF_LIF, abrogation of GP130 receptor or addition of a specific LIF blocking antibody failed to alter STAT3 phosphorylation, which contrasts with the abrogation of JAK1 expression (Supplementary Fig. 1c,d). Taken together, these data demonstrate that LIF confers permanent proinvasive conversion to hDF that is independent of a LIF autocrine signalling regulatory loops but dependent on JAK1 activity. We thus hypothesized that epigenetic modifications might be involved in the constitutive activation of CAF and hDF_LIF. To test this idea, HN-CAF-dependent three-dimensional matrix gel contraction assays were performed in the presence of 45 small-molecule inhibitors targeting the epigenetic and DNA-modifier cell machinery (Fig. 1e, Supplementary Fig. 1e and Supplementary Table 1). For each tested molecule, the screen was performed at optimized concentrations (Supplementary Table 1); dimethylsulphoxide was used as a control. Among the six classes of inhibitors, three HAT p300 inhibitors (Garcinol, Anacardic acid and C646) and three DNA methyltransferase inhibitors (5′-Aza-2′-deoxycytidine, Zebularine and Decitabine) blocked the CAF contractile capacity (Fig. 1e). Accordingly, the p300 activator CTPB (N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxy-benzamide) significantly increased CAF contractility (Fig. 1e). Inhibition of matrix remodelling by both p300 and DNMT inhibitors was further confirmed in hDF_LIF (Supplementary Fig. 1e). In light of these results, the role of p300 in CAF- and hDF-LIF-dependent SCC12 cell invasion was further investigated. Using C646, a small-molecule inhibitor, the crucial role of p300 in proinvasive activity